Celularity Inc. Derivative Liability, Noncurrent
Celularity Inc. (CELU) had Derivative Liability, Noncurrent of $29.35 million as of 2021-06-30, per its 10-Q filed 2021-08-19.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2021-08-19
- 2021-06-30: Derivative Liability, Noncurrent $29.35M.
- 2021-03-31: Derivative Liability, Noncurrent $23.79M.
- 2020-12-31: Derivative Liability, Noncurrent $63.80M.
| Period end | Derivative Liability, Noncurrent |
|---|---|
| 2021-06-30 | $29.35M 10-Q · filed 2021-08-19 |
| 2021-03-31 | $23.79M 10-Q · filed 2021-05-24 |
| 2020-12-31 | $63.80M 10-Q · filed 2021-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |